Management of seborrheic dermatitis and pityriasis versicolor

American Journal of Clinical Dermatology
J Faergemann

Abstract

Pityriasis (tinea) versicolor and seborrheic dermatitis are two very common skin diseases. Pityriasis versicolor is a chronic superficial fungal disease usually located on the upper trunk, neck, or upper arms. In pityriasis versicolor, the lipophilic yeast Malassezia (also know as Pityrosporum ovale or P. orbiculare) changes from the blastospore form to the mycelial form under the influence of predisposing factors. The most important exogenous factors are high temperatures and a high relative humidity which probably explain why pityriasis versicolor is more common in the tropics. The most important endogenous factors are greasy skin, hyperhidrosis, hereditary factors, corticosteroid treatment and immunodeficiency. There are many ways of treating pityriasis versicolor topically. Options include propylene glycol, ketoconazole shampoo, zinc pyrithione shampoo, ciclopiroxamine, selenium sulfide, and topical antifungals. In difficult cases, short term treatment with fluconazole or itraconazole is effective and well tolerated. To avoid recurrence a prophylactic treatment regimen is mandatory. Seborrheic dermatitis is characterized by red scaly lesions predominantly located on the scalp, face and upper trunk. There are now many studie...Continue Reading

References

Jul 11, 1975·Deutsche medizinische Wochenschrift·K J SchwarzM Konzelmann
May 1, 1990·Journal of the American Academy of Dermatology·M KiefferE Svejgaard
Sep 1, 1991·Clinical and Experimental Dermatology·I M BergbrantT Söderström
Sep 1, 1990·Journal of the American Academy of Dermatology·J Delescluse
Jun 1, 1989·Mycoses·J Faergemann
Apr 1, 1985·The British Journal of Dermatology·R MarksA P Walker
May 1, 1985·Journal of the American Academy of Dermatology·R B SkinnerE W Rosenberg
Apr 1, 1986·Journal of the American Academy of Dermatology·E Hernández-Pérez
Sep 1, 1986·Journal of the American Academy of Dermatology·R C Savin, S N Horwitz
Jun 1, 1972·The British Journal of Dermatology·T Fredriksson
Apr 1, 1969·The British Journal of Dermatology·S O Roberts
Apr 1, 1965·Archives of Dermatology·S D Albright, J M Hitch
Nov 1, 1984·The British Journal of Dermatology·G P FordS Shuster
Nov 1, 1984·Clinical and Experimental Dermatology·R J Hay, G Midgeley
Aug 1, 1984·The British Journal of Dermatology·S Shuster
Feb 1, 1983·The Journal of Investigative Dermatology·P G Sohnle, C Collins-Lech
May 1, 1996·Antonie van Leeuwenhoek·E GuéhoJ Guillot
Feb 18, 1998·International Journal of Dermatology·M A Amer
Apr 29, 1998·Journal of the European Academy of Dermatology and Venereology : JEADV·T PariK Thomas
Oct 10, 1998·The British Journal of Dermatology·M E Parry, G R Sharpe
Nov 17, 1999·Clinical and Experimental Dermatology·I M BergbrantJ Faergemann

❮ Previous
Next ❯

Citations

Sep 6, 2003·Dermatologic Clinics·Aditya K GuptaJan Faergemann
Dec 20, 2002·Clinics in Dermatology·Marcia Ramos-e-SilvaAna Libia Cardozo Pereira
Jan 10, 2002·Clinical Microbiology Reviews·H Ruth Ashbee, E Glyn V Evans
Oct 5, 2002·Clinical Microbiology Reviews·Jan Faergemann
Aug 23, 2005·Infection and Immunity·Jill R Blankenship, Joseph Heitman
Jan 25, 2005·American Journal of Clinical Dermatology·Aditya K GuptaRoma Batra
Jan 29, 2010·Medical Mycology·Takamasa KanekoKoichi Makimura
Apr 22, 2005·The Journal of Dermatology·Kamer GündüzHandan Sacar
Mar 28, 2008·Expert Opinion on Investigational Drugs·Jeanette Jacobsson Sundberg, Jan Faergemann
Jun 15, 2007·Expert Opinion on Pharmacotherapy·Jan FaergemannH Degreef
Dec 31, 2005·The Journal of Investigative Dermatology. Symposium Proceedings·Yvonne M DeAngelisThomas L Dawson
Oct 16, 2009·Journal of the American Academy of Dermatology·Jan FaergemannManuel Briones
Jul 11, 2009·Pediatric Annals·Gabriele B PoindexterDean S Morrell
Aug 2, 2003·International Journal of Dermatology·Rafet KocaEmel Eştürk
Jan 21, 2009·Periodontology 2000·Jan Faergemann, Gunnar Dahlén
Sep 27, 2007·Journal of the European Academy of Dermatology and Venereology : JEADV·M R ZampinoA Virgili
Oct 12, 2013·International Journal of Dermatology·Lorena DantasPaulo Machado
Nov 4, 2004·Journal of the American Academy of Dermatology·Aditya K GuptaThomas L Dawson
Jul 22, 2004·Expert Opinion on Pharmacotherapy·Aditya K Gupta, Nataly Kogan
Jun 14, 2016·Scientific Reports·Andrew G S WarrilowSteven L Kelly
Mar 19, 2014·Journal of Cutaneous Medicine and Surgery·Aditya K GuptaMaryse Paquet
Mar 9, 2005·Journal of the European Academy of Dermatology and Venereology : JEADV·O KoseA R Gur
Mar 16, 2005·Skin Pharmacology and Physiology·C Piérard-FranchimontG E Piérard
Oct 26, 2005·Skin Pharmacology and Physiology·C Piérard-FranchimontG E Piérard
Dec 2, 2005·Dermatology : International Journal for Clinical and Investigative Dermatology·Gérald E PiérardClaudine Piérard-Franchimont
Oct 1, 2020·BMC Dermatology·Mariusz DylągLukasz Kozubowski
Jan 4, 2006·International Journal of Immunopathology and Pharmacology·G A VenaE Peruzzi
Jan 13, 2022·Microbiology Spectrum·Juanjuan LiDongmei Shi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.